Agency has finally issued its new rule on contraceptive coverage.
Now that Howard Shelanski is confirmed, he faces choices about his priorities.
Howard Shelanski questioned on delays, retrospective review, and role for cost-benefit analysis.
Agency needs “wake-up call” on chemical hazards, says PPR’s Adam Finkel.
Bioethics Commission weighs in on ethical ways to test anthrax vaccines on children.
Industry lobbyists and safety advocates testify to the benefits and burdens of two major proposed rules.